Evaluation of the Safety and Efficacy of Long-term Use of Omega-3 Fatty Acid Ethyl Esters

NCT02153073 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3084

Last updated 2019-07-18

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate the safety and efficacy of long-term use of granular capsule formulation of omega-3 fatty acid ethyl esters (Lotriga Granular Capsules) in patients with hyperlipidemia in daily medical practice

Conditions

Interventions

DRUG

Omega-3 fatty acid ethyl esters

Omega-3 fatty acid ethyl esters granular capsules

Sponsors & Collaborators

Principal Investigators

  • Study Director · Takeda

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-05-29
Primary Completion
2017-05-31
Completion
2017-05-31

Countries

  • Japan

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02153073 on ClinicalTrials.gov